News + Resources
PULSE Statement on Finalized Joint Merger Guidelines from FTC, DOJ
Latest guidance could pose unintended consequences for life science ecosystem, pro-innovation M&A Washington, D.C. – In response to the latest merger guidelines released today by the Federal Trade Commission (FTC) and Department of Justice (DOJ), the Partnership...
Opinion: Proposed regulation would limit life-saving research in Ohio
Ohio has had incredible success in the life sciences in recent years. The first-ever novel gene therapy brain infusion for Parkinson’s disease was developed here, along with the first-ever gene therapy treatment for Duchenne’s muscular dystrophy. Add state-of-the-art...
In Case You Missed It: PULSE Webinar – Life Science M&A: Supporting the Next Generation of Biopharma Breakthroughs
To view the full event recording, click here. Across the life sciences industry, companies engage in a constant “relay race” to bring new and groundbreaking treatments to market. The critical partnerships and “hand-offs” between companies of all sizes are core...
The Legislative Pillars Supporting Innovation & Access in the Life Sciences Ecosystem
For nearly four decades, policymakers have prioritized bipartisan policies that incentivize investment in groundbreaking medical research – aiming to make new innovations accessible for millions of Americans.
Life Sciences Companies Leverage M&A, Specialized Expertise to Advance Biopharmaceutical Breakthroughs
Over the past several decades, the U.S. life sciences ecosystem has emerged as a global leader in innovation with more than 2,300 biopharmaceutical companies spanning every state. Pro-innovation mergers and acquisitions (M&A) have been a critical component of the...